Tonix Pharmaceuticals Holding Corp. TNXP
$8.07
-9.43%
at last close
Analyst Consensus
- Consensus Rating
- Buy (2 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $24.00
- Implied Upside
- +197.4%
- Price Target Range
- $22.00 – $26.00
- Analysts (12 mo)
- 2
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-06-25 | Raymond JamesTiago Fauth |
Initiates coverage on | Strong buy | $26 |
| 2026-05-04 | TD CowenStacy Ku |
Initiates coverage on | Buy | $22 |
| 2025-03-20 | Noble Capital MarketsRobert LeBoyer |
Reiterates | Outperform | $70 |
| 2024-07-22 | Alliance Global PartnersJames Molloy |
Maintains | Buy | $600 → $1100 |
| 2024-02-28 | Dawson JamesJason Kolbert |
Initiates coverage on | Buy | $9600 |
| 2023-08-01 | Alliance Global PartnersJames Molloy |
Maintains | Buy | $57600 → $25600 |
| 2023-06-02 | Alliance Global PartnersJames Molloy |
Maintains | Buy | $20800 → $57600 |
| 2023-01-12 | Alliance Global PartnersJames Molloy |
Reiterates | Buy | $129984 |
| 2022-04-18 | Noble Capital MarketsRobert LeBoyer |
Initiates coverage on | Outperform | $384000 |
| 2021-08-31 | Alliance Global PartnersJames Molloy |
Maintains | Buy | $6400 → $9600 |
| 2021-08-11 | Alliance Global PartnersJames Molloy |
Maintains | Buy | $12800 → $6400 |
| 2021-02-25 | Alliance Global PartnersJames Molloy |
Maintains | Buy | $9600 → $12800 |
| 2019-04-18 | Roth CapitalScott Henry |
Upgrades | Neutral → Buy | — |
| 2018-07-27 | B. Riley Securities |
Downgrades | Buy → Neutral | — |
| 2018-07-27 | Roth CapitalScott Henry |
Downgrades | Buy → Neutral | — |
| 2018-06-06 | B. Riley Securities |
Initiates coverage on | Buy | $512000000 |
| 2017-08-18 | Roth CapitalScott Henry |
Upgrades | Neutral → Buy | — |
| 2016-09-07 | Roth CapitalScott Henry |
Downgrades | Buy → Neutral | — |
| 2016-09-07 | Cantor Fitzgerald |
Downgrades | Buy → Hold | — |
| 2016-06-02 | Cantor Fitzgerald |
Upgrades | Speculative buy → Buy | — |
| 2016-02-17 | Oppenheimer |
Maintains | Outperform | $11520000000 → $6400000000 |
| 2016-02-17 | Cantor Fitzgerald |
Downgrades | Buy → Speculative buy | — |
| 2015-11-04 | Cantor Fitzgerald |
Initiates coverage on | Buy | — |
| 2015-06-12 | Oppenheimer |
Initiates coverage on | Outperform | $11520000000 |
| 2015-05-07 | Janney Montgomery Scott |
Initiates coverage on | Buy | $6400000000 |
| 2015-05-06 | Janney Montgomery Scott |
Initiates coverage on | Buy | — |
| 2013-10-01 | Roth CapitalScott Henry |
Initiates coverage on | Buy | $5440000000 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $8.07
- Market Cap
- $138.41 million
- 52-Week Range
- $8.00 – $31.55
- Average Volume
- 500K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.